Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001916048-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 23, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
22,314
Total Value
$298,364.21
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jul 21, 2026 | Exercise/Conversion | 7,438 | $13.24 | $98,479.12 | 45,838 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Jul 21, 2026 | Sale | 7,438 | $26.87 | $199,885.09 | 38,400 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option | Derivative | Jul 21, 2026 | Exercise/Conversion | 7,438 | $0.00 | $0.00 | 245,438 | Direct | โ | View Details |